Cargando…
EFFECT OF AN INTRAVITREAL DEXAMETHASONE IMPLANT ON DIABETIC MACULAR EDEMA AFTER CATARACT SURGERY
PURPOSE: To analyze the effects of a dexamethasone intravitreal implant (DEX; Ozurdex 700 μg; Allergan) administered immediately after cataract surgery in diabetic patients. METHODS: This prospective, single-arm, open label study (NCT01748487 at ClinicalTrials.gov) involved Type 2 diabetic patients...
Autores principales: | Calvo, Pilar, Ferreras, Antonio, Al Adel, Fadwa, Dangboon, Wantanee, Brent, Michael H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Retina
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5841849/ https://www.ncbi.nlm.nih.gov/pubmed/28196056 http://dx.doi.org/10.1097/IAE.0000000000001552 |
Ejemplares similares
-
Results of intravitreal dexamethasone implant (Ozurdex(®)) for retinal vascular diseases with macular edema: An observational study of real-life situations
por: Jirarattanasopa, Pichai, et al.
Publicado: (2022) -
DIABETIC MACULAR EDEMA AND CATARACT SURGERY: Phacoemulsification Combined With Dexamethasone Intravitreal Implant Compared With Standard Phacoemulsification
por: Furino, Claudio, et al.
Publicado: (2021) -
Combined Phacoemulsification and Intravitreal Dexamethasone Implant (Ozurdex®) in Diabetic Patients with Coexisting Cataract and Diabetic Macular Edema
por: Furino, Claudio, et al.
Publicado: (2017) -
Pre-operative intravitreal dexamethasone implant in patients with refractory diabetic macular edema undergoing cataract surgery
por: Kabanarou, Stamatina A., et al.
Publicado: (2020) -
Real-world experience on intravitreal dexamethasone implant in patients with macular edema scheduled to undergo cataract surgery
por: Lai, Chun-Chieh, et al.
Publicado: (2023)